Novartis Ag (NVSEF) Treasury Shares (2009 - 2026)

Novartis Ag has disclosed Treasury Shares across 13 years of filings, most recently posting -$47.0 million for Q1 2026.

• Treasury Shares for Q1 2026 came in at -$47.0 million, down 147.37% year-over-year; the trailing twelve-month figure through Mar 2026 was -$47.0 million (down 147.37% YoY), and the FY2025 annual result was -$50.0 million, up 5.66% from the prior year.
• Treasury Shares came in at -$47.0 million for Q1 2026 at Novartis Ag, up from -$50.0 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $92.0 million in Q4 2022 to a low of -$70.0 million in Q3 2022.
• The 5-year median for Treasury Shares is -$40.0 million (2024), against an average of -$29.7 million.
• Across the five-year window, Treasury Shares jumped 91.67% in 2022 and plunged 229.27% in 2024, its largest moves.
• Novartis Ag's Treasury Shares stood at $92.0 million in 2022, then slumped by 55.43% to $41.0 million in 2023, then slumped by 229.27% to -$53.0 million in 2024, then advanced by 5.66% to -$50.0 million in 2025, then gained by 6.0% to -$47.0 million in 2026.
• The last three Treasury Shares figures came in at -$47.0 million (Q1 2026), -$50.0 million (Q4 2025), and -$44.0 million (Q3 2025), per Business Quant data.